Gene · 4739
NIH grants1,451
NIH grants whose papers are about the gene, through NIH's grant-paper links.
141 to 160 of 1,451
Download this page as JSON| Grant | Title | NEDD9 papers | Newest fiscal year |
|---|---|---|---|
| R01DK076077 | Adaptive and maladaptive repair after kidney injury | 1 | 2025 |
| R01DK117850 | Systems Genetics Dissection of Non-alcoholic Steatohepatitis | 1 | 2025 |
| R01DK132781 | Primary cilia loss in bile duct cells- the interplay with the autophagy machinery | 1 | 2025 |
| R01DK139598 | Leveraging metabolic pathways and gene expression data to propel understanding of severe obesity | 1 | 2025 |
| R01ES027778 | Mechanism for arsenic induced carcinogenesis | 1 | 2025 |
| R01EY021797 | Development of Stem Cell-based Therapies for Limbal Stem Cell Deficiency | 1 | 2025 |
| R01EY026104 | Cellular and Genetic Defects in Keratoconus | 1 | 2025 |
| R01EY027824 | Regulation of blood-retina barrier by placental growth factor | 1 | 2025 |
| R01EY028560 | The Roles of Autophagy in Limbal/Corneal Epithelia | 1 | 2025 |
| R01EY032561 | Targeting epithelial membrane protein 2 (EMP2) in retinopathy of prematurity | 1 | 2025 |
| R01GM031530 | Superchanneling, Regulation of Caspases, and Site-Specific Control of RNA | 1 | 2025 |
| R01GM089846 | Role of DNA structural dynamics in mutagenesis and oncogenesis | 1 | 2025 |
| R01GM141329 | Investigating the metal-dependent function, allostery and inhibition of CRISPR-Cas9 | 1 | 2025 |
| R01HD020676 | Trophoblast Differentiation | 1 | 2025 |
| R01HG002385 | Long-read sequence and assembly of segmental duplications | 1 | 2025 |
| R01HG010632 | Versatile, exponentially scalable methods for single cell molecular profiling | 1 | 2025 |
| R01HG012117 | Novel Use of Genome Information to Understand Mutations | 1 | 2025 |
| R01HL109557 | Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle | 1 | 2025 |
| R01HL124021 | An endothelial-fibroblast axis connecting senescence to amino acid metabolism for control of vascular stiffness in PAH | 1 | 2025 |
| R01HL132918 | Anaplerotic reprogramming of endothelial cells in pulmonary hypertension | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4739/grants?page=8